Summary
This prediction ended on 20.05.16 with a price of €89.44. With a performance of -5.23%, the BUY prediction by Subdi finished with a loss. Subdi has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 3.629% | 3.629% | 83.059% | -32.543% |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% | 45.717% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% | 73.262% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% | 48.769% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% | 55.803% |
Comments by Subdi for this prediction
In the thread Bayer AG diskutieren
Subdi stimmt der Buy-Einschätzung von HHstudent zu
Bayer erhöht die Dividende das sechste Jahr in Folge
http://mydividends.de/content/bayer-erh%C3%B6ht-die-dividende-das-sechste-jahr-folge
Subdi stimmt am 28.02.2016 der Buy-Einschätzung von HHstudent mit dem Kursziel 135€ zu.
Überschrift: Bayer aktuell 35% billiger zu haben als vor knapp einem Jahr